Pesquisas alternativas:
armed phase » formed phase (Expandir a Pesquisa), aided phase (Expandir a Pesquisa), red phase (Expandir a Pesquisa)
safety one » safety zone (Expandir a Pesquisa), safety zones (Expandir a Pesquisa), safety over (Expandir a Pesquisa)
armed case » armed scale (Expandir a Pesquisa), armed canine (Expandir a Pesquisa), armenia case (Expandir a Pesquisa)
armed phase » formed phase (Expandir a Pesquisa), aided phase (Expandir a Pesquisa), red phase (Expandir a Pesquisa)
safety one » safety zone (Expandir a Pesquisa), safety zones (Expandir a Pesquisa), safety over (Expandir a Pesquisa)
armed case » armed scale (Expandir a Pesquisa), armed canine (Expandir a Pesquisa), armenia case (Expandir a Pesquisa)
301
Por Nakayama, Goro, Uehara, Keisuke, Ishigure, Kiyoshi, Yokoyama, Hiroyuki, Ishiyama, Akiharu, Eguchi, Takehiko, Tsuboi, Kenji, Ohashi, Norifumi, Fujii, Tsutomu, Sugimoto, Hiroyuki, Koike, Masahiko, Fujiwara, Michitaka, Ando, Yuich, Kodera, Yasuhiro
Publicado em 2012
“... %, DCR of 89.4 %, and median PFS of 13.1 months (95 % CI, 8.7–17.5 months). Thirty-one patients went...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
302
Por A. Daniels, Emily.
Publicado em 2012
“... case study examines the practices of two transformative urban educators, around caring and armed love...”Publicado em 2012
Obter o texto integral
Livro
303
Por Ohtsu, Atsushi, Ajani, Jaffer A., Bai, Yu-Xian, Bang, Yung-Jue, Chung, Hyun-Cheol, Pan, Hong-Ming, Sahmoud, Tarek, Shen, Lin, Yeh, Kun-Huei, Chin, Keisho, Muro, Kei, Kim, Yeul Hong, Ferry, David, Tebbutt, Niall C., Al-Batran, Salah-Eddin, Smith, Heind, Costantini, Chiara, Rizvi, Syed, Lebwohl, David, Van Cutsem, Eric
Publicado no J Clin Oncol (2013)
“....7 months and 1.4 months in the everolimus and placebo arms, respectively (hazard ratio, 0.66; 95% CI, 0.56...”Publicado no J Clin Oncol (2013)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
304
Por Van Damme, L., Wright, A., Depraetere, K., Rosenstein, I., Vandersmissen, V., Poulter, L., McKinlay, M., Van Dyck, E., Weber, J., Profy, A., Laga, M., Kitchen, V.
Publicado em 2000
“... cohort where samples were taken 12 hours after the last gel application. Conclusion: In this phase I...”Publicado em 2000
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
305
Por Jamshidi, Ahmadreza, Gharibdoost, Farhad, Vojdanian, Mahdi, Soroosh, Soosan G., Soroush, Mohsen, Ahmadzadeh, Arman, Nazarinia, Mohammad Ali, Mousavi, Mohammad, Karimzadeh, Hadi, Shakibi, Mohammad Reza, Rezaieyazdi, Zahra, Sahebari, Maryam, Hajiabbasi, Asghar, Ebrahimi, Ali Asghar, Mahjourian, Najmeh, Rashti, Amin Mohammadinejad
Publicado no Arthritis Res Ther (2017)
“... values >0.05). Further, the difference in HAQ scores and safety outcome measures between treatment arms...”Publicado no Arthritis Res Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
306
Por Sheppard, Michael, Bronstein, Marcello D., Freda, Pamela, Serri, Omar, De Marinis, Laura, Naves, Luciana, Rozhinskaya, Liudmila, Hermosillo Reséndiz, Karina, Ruffin, Matthieu, Chen, YinMiao, Colao, Annamaria
Publicado no Pituitary (2014)
“...PURPOSE: A large, randomized, double-blind, Phase III core study demonstrated that pasireotide LAR...”Publicado no Pituitary (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
307
Por Knight, Beverly, Rassam, Danielle, Liao, Shanmei, Ewesuedo, Reginald
Publicado no Cancer Chemother Pharmacol (2016)
“..., were randomized 1:1:1 to receive a single 5 mg/kg intravenous dose of PF-06439535, bevacizumab-EU...”Publicado no Cancer Chemother Pharmacol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
308
Por von Rosenstiel, P, Gheuens, S, O’Gorman, J, Chiao, P, Hock, C, Nitsch, R, Budd Haeberlein, S, Sandrock, A
Publicado no Innov Aging (2018)
“...PRIME is an ongoing Phase 1b study evaluating safety, tolerability, and PK/PD of aducanumab...”Publicado no Innov Aging (2018)
Obter o texto integral
Obter o texto integral
Artigo
309
Por Maitland, Michael L., Piha-Paul, Sarina, Falchook, Gerald, Kurzrock, Razelle, Nguyen, Ly, Janisch, Linda, Karovic, Sanja, McKee, Mark, Hoening, Elizabeth, Wong, Shekman, Munasinghe, Wijith, Palma, Joann, Donawho, Cherrie, Lian, Guinan K., Ansell, Peter, Ratain, Mark J., Hong, David
Publicado no Br J Cancer (2018)
“... with advanced solid tumours participated in a phase 1 dose-escalation trial to profile the safety, tolerability...”Publicado no Br J Cancer (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
310
Por Souweidane, Mark M, Kramer, Kim, Pandit-Taskar, Neeta, Zhou, Zhiping, Haque, Sofia, Zanzonico, Pat, Carrasquillo, Jorge A, Lyashchenko, Serge K, Thakur, Sunitha B, Donzelli, Maria, Turner, Ryan S, Lewis, Jason S, Cheung, Nai-Kong V, Larson, Steven M, Dunkel, Ira J
Publicado no Lancet Oncol (2018)
“... with diffuse intrinsic pontine glioma. METHODS: We did a phase 1, single-arm, single-centre, dose-escalation...”Publicado no Lancet Oncol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
311
Por Lachmann, Raskit, Bevan, Margaret A., Kim, Sangmi, Patel, Nishma, Hawrylowicz, Catherine, Vyakarnam, Annapurna, Peters, Barry S.
Publicado no AIDS (2015)
“.... DESIGN: This was a pilot, open-label, three-arm prospective phase 1 study. METHODS: We recruited 28...”Publicado no AIDS (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
312
Por Keizman, Daniel, Zahurak, Marianna, Sinibaldi, Victoria, Carducci, Michael, Denmeade, Samuel, Drake, Charles, Pili, Roberto, Antonarakis, Emmanuel S., Hudock, Susan, Eisenberger, Mario
Publicado em 2010
“...PURPOSE: To evaluate the safety and activity of 6 months of treatment with lenalidomide at 5 or 25...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
313
Phase II studies to select the formulation of a multivalent HPV L1 virus-like particle (VLP) vaccine
Por Luxembourg, Alain, Brown, Darron, Bouchard, Celine, Giuliano, Anna R, Iversen, Ole-Erik, Joura, Elmar A, Penny, Mary E, Restrepo, Jaime A, Romaguera, Josefina, Maansson, Roger, Moeller, Erin, Ritter, Michael, Chen, Joshua
Publicado no Hum Vaccin Immunother (2015)
“... types by conducting 3 Phase II studies comparing the immunogenicity (i.e., anti-HPV6/11/16/18 geometric...”Publicado no Hum Vaccin Immunother (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
314
Por Mahalingam, Devalingam, Wilkinson, Grey A, Eng, Kevin H., Fields, Paul, Raber, Patrick, Moseley, Jennifer L., Cheetham, Karol, Coffey, Matt, Nuovo, Gerard, Kalinski, Pawel, Zhang, Bin, Arora, Sukeshi Patel, Fountzilas, Christos
Publicado no Clin Cancer Res (2019)
“... and effective. METHODS: A phase 1b single arm study enrolled PDAC patients who progressed after first-line...”Publicado no Clin Cancer Res (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
315
Por Mark Yarchoan, Chiung‐Yu Huang, Qingfeng Zhu, Anna K. Ferguson, Jennifer N. Durham, Robert A. Anders, Elizabeth D. Thompson, Noah S. Rozich, Dwayne L. Thomas II, Julie M. Nauroth, Christina Rodriguez, Arsen Osipov, Ana De Jesus‐Acosta, Dung T. Le, Adrian G. Murphy, Daniel Laheru, Ross C. Donehower, Elizabeth M. Jaffee, Lei Zheng, Nilofer S. Azad
Publicado em 2020-02-01
Assuntos:
“...PD-1...”Publicado em 2020-02-01
Obter o texto integral
Artigo
316
Por Veldhuijzen van Zanten, Sophie E. M., El-Khouly, Fatma E., Jansen, Marc H. A., Bakker, Dewi P., Sanchez Aliaga, Esther, Haasbeek, Cornelis J. A., Wolf, Nicole I., Zwaan, C. Michel, Vandertop, W. Peter, van Vuurden, Dannis G., Kaspers, Gertjan J. L.
Publicado no J Neurooncol (2017)
“...The purpose of this phase I/II, open-label, single-arm trial is to investigate the safety...”Publicado no J Neurooncol (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
317
Por Von Hoff, Daniel D., Rasco, Drew W., Heath, Elisabeth I., Munster, Pamela N., Schellens, Jan H.M., Isambert, Nicolas, Le Tourneau, Christophe, O’Neil, Bert, Mathijssen, Ron H.J., Lopez-Martin, Jose A., Edenfield, W. Jeff, Martin, Miguel, LoRusso, Patricia M., Bray, Gordon L., DiMartino, Jorge, Nguyen, Aaron, Liu, Kejian, Laille, Eric, Bendell, Johanna C.
Publicado no Clin Cancer Res (2018)
“...PURPOSE: This large two-part, three-arm phase I study examined the safety and tolerability of CC...”Publicado no Clin Cancer Res (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
318
Por Chakravarti, Arnab, Wang, Meihua, Robins, H. Ian, Lautenschlaeger, Tim, Curran, Walter J., Brachman, David G., Schultz, Christopher J., Choucair, Ali, Dolled-Filhart, Marisa, Christiansen, Jason, Gustavson, Mark, Molinaro, Annette, Mischel, Paul, Dicker, Adam P., Bredel, Markus, Mehta, Minesh
Publicado em 2012
“.../21/2002 and 5/03/2004 RTOG 0211 enrolled 31 and 147 GBM patients in the phase I and II arms...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
319
Por Pal, Sumanta, Azad, Arun, Bhatia, Shailender, Drabkin, Harry, Costello, Brian, Sarantopoulos, John, Kanesvaran, Ravindran, Lauer, Richard, Starodub, Alexander, Hauke, Ralph, Sweeney, Christopher J., Hahn, Noah M., Sonpavde, Guru, Richey, Stephen, Breen, Timothy, Kremmidiotis, Gabriel, Leske, Annabell, Doolin, Elizabeth, Bibby, David C., Simpson, Jeremy, Iglesias, Jose, Hutson, Thomas
Publicado no Clin Cancer Res (2015)
“... with everolimus. In this phase I/II study, efficacy and safety of the combination were explored in patients...”Publicado no Clin Cancer Res (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
320
Por Zelenetz, Andrew D., Salles, Gilles, Mason, Kylie D., Casulo, Carla, Le Gouill, Steven, Sehn, Laurie H., Tilly, Herve, Cartron, Guillaume, Chamuleau, Martine E. D., Goy, Andre, Tam, Constantine S., Lugtenburg, Pieternella J., Petrich, Adam M., Sinha, Arijit, Samineni, Divya, Herter, Sylvia, Ingalla, Ellen, Szafer-Glusman, Edith, Klein, Christian, Sampath, Deepak, Kornacker, Martin, Mobasher, Mehrdad, Morschhauser, Franck
Publicado no Blood (2019)
“... phase 1b study investigating dose escalation of the BCL2 inhibitor, venetoclax, in combination...”Publicado no Blood (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo